Polypoidal Choroidal Vasculopathy clinical trials

The registry lists 54 studies for Polypoidal Choroidal Vasculopathy across more than 10 countries. 6 are recruiting or about to start. 42 of them are mainly about Polypoidal Choroidal Vasculopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-25.

Get an email when these change. Save the Polypoidal Choroidal Vasculopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 27
Status unknown: 15
Recruiting: 5
Terminated: 3
Withdrawn: 2
Not yet recruiting: 1

Phase

Phase 4: 17
Phase 2: 9
Phase 1: 7
Phase 3: 6

Where

Korea, Republic of: 16
United States: 13
China: 11
Singapore: 6
Thailand: 5
Italy: 3

Who runs them

Singapore National Eye Centre (4) · Southeast Retina Center, Georgia (3) · Sun Yat-sen University (3) · Yeungnam University College of Medicine (3) · Samsung Medical Center (2) · Ophthotech Corporation (2) · Peking Union Medical College Hospital (2) · Association for Innovation and Biomedical Research on Light and Image (2)

What is being tested here

Drugs under test in Polypoidal Choroidal Vasculopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Faricimab	2	1	2
Aflibercept	1	1	10
Ranibizumab	0	0	8
Avacincaptad pegol	0	0	2
Verteporfin	0	0	2
Bevacizumab	0	1	2
Brolucizumab	0	1	1
Fosbretabulin	0	0	1
Sonepcizumab	0	0	1
Triamcinolone Acetonide	0	0	1

Drug classes tested here Angiogenesis inhibitors 3 open

Coming up

3phase 3 studies under way

0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 5 Polypoidal Choroidal Vasculopathy studies recruiting now, 3 (60%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	1 (20%)	1 (20%)
18	1 (20%)	1 (20%)
30	2 (40%)	2 (40%)
40	2 (40%)	2 (40%)
50	5 (100%)	5 (100%)
65	5 (100%)	5 (100%)
75	5 (100%)	5 (100%)
85	5 (100%)	5 (100%)

Across all 54 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 7% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.